Crossmark

Recommendations on the treatment of metastatic hormone-sensitive prostate cancer: Patient selection

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2024.05.008

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Borque-Fernando, Á.

Zapatero, A.

Manneh, R.

Alonso-Gordoa, T.

Couñago, F.

Domínguez-Esteban, M.

López-Valcárcel, M.

Rodríguez-Antolín, A.

Sala-González, N.

Sanmamed, N.

Maroto, P.
Funding

Funding for this research was provided by:

Bayer (GPP-2022)
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-07-25
More Information

This article is maintained by: Elsevier

Article Title: Recommendations on the treatment of metastatic hormone-sensitive prostate cancer: Patient selection

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2024.05.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2024.03.002

Content Type: simple-article

Copyright: © 2024 The Authors. Published by Elsevier España, S.L.U. on behalf of AEU.